KCNQ1OT1 and hepatocellular carcinoma: In addition, it has been reported to modulate OXA resistance through the miR-75p/ABCC1 (ATP Binding Cassette Subfamily C Member 1) axis in HepG2 and Huh HCC cells, indicating that KCNQ1OT1 may be a novel therapeutic target for HCC [28].